Genetic and molecular aspects of Helicobacter pylori in gastritis, pre- cancerous conditions and gastric adenocrcinoma
- PMID: 26171133
- PMCID: PMC4495423
Genetic and molecular aspects of Helicobacter pylori in gastritis, pre- cancerous conditions and gastric adenocrcinoma
Abstract
Gastric adenocarcinoma is one of the most common malignancies worldwide. Many ethological causes have been introduced among which helicobacter pylori, as a gram-negative bacterium has been considered as an important pathological facilitating factor. This agent is also associated with different digestive diseases, such as gastritis, peptic ulcer, and mucosa-associated lymphoid tissue lymphoma. Recently, scientists have been described some molecular aspects that show the role of some apoptotic genes and proteins; for example: P53, Bcl2, C-Myc and Rb-suppressor systems in the H. pylori pathogenesis. Also the relationship between nitric oxide (NOSi genotype) with H. pylori infection has been shown. The aim of this mini-review is to explain better these genetically aspects of H.pylori pathogenesis.
Keywords: Apoptosis; C-Myc; Gastritis; Helicobacter pylori; P53.
Figures
Similar articles
-
Mutant p53 expression and apoptotic activity of Helicobacter pylori positive and negative gastritis in correlation with the presence of intestinal metaplasia.Eur J Gastroenterol Hepatol. 2003 Apr;15(4):389-93. doi: 10.1097/00042737-200304000-00009. Eur J Gastroenterol Hepatol. 2003. PMID: 12655259
-
Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer.Scand J Gastroenterol Suppl. 1993;196:3-6. doi: 10.3109/00365529309098333. Scand J Gastroenterol Suppl. 1993. PMID: 8341988 Review.
-
Helicobacter pylori infection and oncogene expressions in gastric carcinoma and its precursor lesions.Dig Dis Sci. 2002 Jan;47(1):107-13. doi: 10.1023/a:1013223722331. Dig Dis Sci. 2002. PMID: 11837709
-
Assessment of p21, p53 expression, and Ki-67 proliferative activities in the gastric mucosa of children with Helicobacter pylori gastritis.Eur J Gastroenterol Hepatol. 2015 Feb;27(2):155-61. doi: 10.1097/MEG.0000000000000246. Eur J Gastroenterol Hepatol. 2015. PMID: 25533430
-
Association of Helicobacter pylori with gastroduodenal diseases.Jpn J Infect Dis. 1999 Oct;52(5):183-97. Jpn J Infect Dis. 1999. PMID: 10680084 Review.
Cited by
-
A Reverse Vaccinology and Immunoinformatic Approach for the Designing of a Novel mRNA Vaccine Against Stomach Cancer Targeting the Potent Pathogenic Proteins of Helicobacter pylori.Bioinform Biol Insights. 2025 Apr 16;19:11779322251331104. doi: 10.1177/11779322251331104. eCollection 2025. Bioinform Biol Insights. 2025. PMID: 40290636 Free PMC article.
-
The Role of Probiotics in the Eradication of Helicobacter pylori and Overall Impact on Management of Peptic Ulcer: A Study Involving Patients Undergoing Triple Therapy in Bangladesh.Cureus. 2024 Mar 16;16(3):e56283. doi: 10.7759/cureus.56283. eCollection 2024 Mar. Cureus. 2024. PMID: 38495972 Free PMC article.
-
The global prevalence of gastric cancer in Helicobacter pylori-infected individuals: a systematic review and meta-analysis.BMC Infect Dis. 2023 Aug 19;23(1):543. doi: 10.1186/s12879-023-08504-5. BMC Infect Dis. 2023. PMID: 37598157 Free PMC article.
-
Status of Epstein-Barr Virus Coinfection with Helicobacter pylori in Gastric Cancer.J Oncol. 2017;2017:3456264. doi: 10.1155/2017/3456264. Epub 2017 Mar 21. J Oncol. 2017. PMID: 28421114 Free PMC article. Review.
References
-
- ZhuY , Shu X, Chen J. Effect of Helicobacter pylori eradication on oncogenes and cell proliferation. Eur J Clin Invest. 2008;38:628–33. - PubMed
-
- Linpisarn S, Suwan W, Lertprasertsuk N, Koosirirat C, Steger F, Prommuangyong H, et al. Helicobacter pylori caga, vaca and icea genotypes in northern thai patients with gastric disease. Southeast Asian J Trop Med Public Health. 2007;38:356–62. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous